Raul D. Santos MD, MSc, PhD
I hope you are staying well during the COVID-19 crisis. It has been extremely hard on all of us as we have been working longer hours to care for our patients and those who have become infected with COVID. We must all stay positive and know that there will be light at the end of the tunnel.
The IAS has been continuing to work hard to develop activities and programs. We are pleased to announce that we have a new collaboration with the National Lipid Association (NLA). When you sign up through the IAS website for the NLA’s Foundations of Lipidology and/or Masters in Lipidology courses, you will receive the same deeply discounted price offered to NLA members. We will be sending out more information on this collaboration as soon as it is live on our website. Keep a lookout for an email with more information.
IAS will be participating in a joint session on “Familial Hypercholesterolemia: The Discordance Between Its Prevalence and Diagnostic Rate” which will be held during the 21st International Vascular Biology Meeting in conjunction with ICoLA Congress and KVBM Annual Meeting which will be held on September 9-12, 2020.
We will also be participating in Great Wall International Congress of Cardiology (GW-ICC). The meeting will be held virtually October 19 -25, 2020. The joint IAS-GWICC session will focus on the Essentials of Residual Risk in Cardiovascular Diseases. The faculty will include Dong Zhao (Epidemiology), Raul Santos (TG-rich lipoproteins), Peter Libby (Inflammation), Changtao Jiang (Microbiota and ceramide), Samia Mora (Lp(a)), Yida Tang (Obesity and Insulin Resistance).
As you read in my message last month, Khalid Al-Rasadi, Principal Investigator, and Frederick Raal, Co- Principal Investigator, have develop a survey “Acute Cardiac Complications of COVID19 in patients with Familial Hypercholesterolemia” to study the impact of COVID19 infection and acute cardiac complications in the MENA and Africa national or regional constituent societies. We are beginning to receive responses and will share the results at the close of the survey.
IAS is joining with the FH Europe Network for the “Global Call to Action in action” campaign. This will be beginning in September and lead up to FH Awareness Day. It is a way for different societies and patient organizations to amplify our efforts in getting the message out about FH.
Stay safe and well,